RongCan Biotech
PrivateLast Round
Series A
Extension
Sep 28, 2025
Total Funding Raised
$14M
Company Overview
RongCan Biotech operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A Extension round in September 2025.
RongCan Biotech is a biotechnology company that develops nucleic acid-based therapeutics, including mRNA vaccines and LNP-based delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RongCan Biotech Comparables
Compare RongCan Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen MagicRNA Biotechnology Co., Ltd. | 89% | |
| Starna Therapeutics | 87% | |
| Immorna Biotherapeutics | 86% |
For institutional investors. Book with your work email.
RongCan Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 28, 2025 | ||||
| Series A | Dec 6, 2023 | ||||
| Early Funding | Apr 6, 2023 | ||||
| Early Funding | Nov 21, 2022 | ||||
| Angel | Jun 15, 2021 |
For institutional investors. Book with your work email.
RongCan Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lilly Asia Ventures | Angel |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2025
Completed a Series A Extension round.
- Dec 6, 2023
$14M round led by Guangzhou Yuexiu Industrial Investment Fund Management
For institutional investors. Book with your work email.
RongCan Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RongCan Biotech's valuation, stock price, and market status.
Is RongCan Biotech a public or private company?
RongCan Biotech is a private company.
What is the current stock price of RongCan Biotech?
RongCan Biotech is a private company, so its shares have no public market price. Caplight tracks RongCan Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RongCan Biotech worth (valuation)?
Valuation information for RongCan Biotech is not publicly available.
Can I buy RongCan Biotech stock?
RongCan Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RongCan Biotech's last funding round?
RongCan Biotech's most recent funding round was Series A Extension on September 28, 2025.
Who are the main investors in RongCan Biotech?
Key investors in RongCan Biotech include Guangzhou Yuexiu Industrial Investment Fund Management.
Will RongCan Biotech IPO soon?
No public IPO plans have been announced for RongCan Biotech.
How can I track RongCan Biotech secondary market activity?
Caplight tracks bids, offers, and trades in RongCan Biotech's shares on secondary markets.